Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has shown significant potential in metabolic research, particularly in studies related to glycemic control and weight management.
Our tirzepatide is produced through advanced chemical synthesis methods to ensure the highest purity standards (99%). The white powder form allows for precise measurement and formulation in various research applications. The product is available in multiple vial sizes to accommodate different research needs.
As a dual receptor agonist, tirzepatide demonstrates unique pharmacological properties by simultaneously targeting both GIP and GLP-1 pathways. This mechanism has shown promising results in preclinical studies for improving metabolic parameters.
Important Note: This product is intended for research purposes only. It is not for human consumption or therapeutic use. All researchers should follow appropriate safety protocols when handling this material.
